lifestyle.longislandreport.org

Author: BrainXell, Inc

BrainXell Launches Human iPSC-Derived Sensory Neurons for Translational Neuroscience and Pain Biology Research

March 4, 2026
BrainXell Showcases Pioneering iPSC Research and Promising In Vivo Data for BXT-110 for Parkinson’s Disease at the 2025 Society for Neuroscience Annual Meeting

November 18, 2025
BrainXell Therapeutics Unveils Promising Preclinical Data Demonstrating Efficacy of BXT-110, an Autologous iPSC-Derived Neuronal Therapy, in Parkinson’s Disease

November 5, 2025